# Entero Therapeutics Inc. (ENTO)

Source: https://www.quantisnow.com/company/ENTO
Generated: 2026-11-13T10:01:51.391Z

- Ticker: ENTO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2016

## Latest ENTO news and filings

- 2025-12-04 22:21 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-entry-into-a-6304008)
- 2025-11-28 13:00 UTC [Market Insight] [Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"](https://www.quantisnow.com/insight/entero-therapeutics-inc-announces-corporate-name-change-to-gridai-technologies-6296034)
- 2025-11-19 22:13 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-entero-therapeutics-inc-6287430)
- 2025-11-19 13:45 UTC [Market Insight] [ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer](https://www.quantisnow.com/insight/ento-subsidiary-grid-ai-announces-letter-of-intent-with-first-6286362)
- 2025-11-17 21:01 UTC [SEC Form NT 10-Q filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-entero-therapeutics-inc-6282800)
- 2025-11-13 19:27 UTC [SEC Form SCHEDULE 13G filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-entero-therapeutics-inc-6277015)
- 2025-11-13 13:35 UTC [Market Insight] [Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy](https://www.quantisnow.com/insight/enteros-grid-ai-prepares-for-major-us-expansion-with-new-6276441)
- 2025-11-06 21:03 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-other-events-financial-6265216)
- 2025-11-06 13:45 UTC [Market Insight] [Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid](https://www.quantisnow.com/insight/entero-subsidiary-grid-ai-accelerates-expansion-into-hyperscaler-ai-data-6264508)
- 2025-10-31 20:00 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-other-events-6254401)
- 2025-10-30 13:00 UTC [Market Insight] [Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)](https://www.quantisnow.com/insight/enteros-reinvention-gives-the-grid-ai-and-investors-exactly-what-6251665)
- 2025-10-30 10:00 UTC [Market Insight] [Entero Regains Nasdaq Compliance With Grid AI Acquisition](https://www.quantisnow.com/insight/entero-regains-nasdaq-compliance-with-grid-ai-acquisition-6250708)
- 2025-10-22 20:01 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-entry-into-a-6241489)
- 2025-10-16 12:40 UTC [Market Insight] [Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid](https://www.quantisnow.com/insight/entero-therapeutics-inc-launches-grid-ai-corp-to-redefine-how-6235137)
- 2025-10-14 15:00 UTC [Market Insight] [From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)](https://www.quantisnow.com/insight/from-biotech-to-grid-tech-entero-therapeutics-enters-a-25-6231994)
- 2025-10-14 12:00 UTC [Market Insight] [Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It](https://www.quantisnow.com/insight/entero-therapeutics-steps-into-the-25-billion-grid-edge-arena-with-6231530)
- 2025-10-06 20:39 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-entry-into-a-6224837)
- 2025-10-01 20:05 UTC [Market Insight] [ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI](https://www.quantisnow.com/insight/entero-therapeutics-ento-enters-100-billion-ai-and-data-center-6217971)
- 2025-09-26 14:00 UTC [SEC Form SEC STAFF ACTION filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sec-staff-action-filed-by-entero-therapeutics-inc-6212738)
- 2025-09-16 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-entero-therapeutics-inc-6201613)
- 2025-09-12 20:30 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-entry-into-a-6199485)
- 2025-09-10 21:19 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-entero-therapeutics-inc-6196909)
- 2025-09-09 20:59 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-termination-of-a-6195377)
- 2025-08-26 20:28 UTC [SEC Form S-1] [SEC Form S-1 filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-entero-therapeutics-inc-6179348)
- 2025-08-26 20:06 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-entero-therapeutics-inc-6179179)
- 2025-08-18 22:58 UTC [SEC Form 3] [SEC Form 3 filed by new insider Pursglove Geordan Garrett](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-pursglove-geordan-garrett-6170643)
- 2025-08-18 22:56 UTC [SEC Form 3] [SEC Form 3 filed by new insider Sawyer Jason David](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-sawyer-jason-david-6170642)
- 2025-08-18 14:40 UTC [SEC Form D] [SEC Form D filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-entero-therapeutics-inc-6169696)
- 2025-08-15 21:09 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-material-modification-to-6168851)
- 2025-08-14 14:59 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-entero-therapeutics-inc-6165152)
- 2025-08-11 13:01 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-entry-into-a-6157741)
- 2025-07-16 20:53 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-entry-into-a-6122402)
- 2025-07-08 20:16 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-other-events-6114286)
- 2025-07-02 21:16 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-entero-therapeutics-inc-6109263)
- 2025-07-02 20:05 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-submission-of-matters-6108133)
- 2025-06-30 20:28 UTC [SEC Form 8-K] [Entero Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/entero-therapeutics-inc-filed-sec-form-8-k-other-events-6103856)
- 2025-06-23 20:06 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-entero-therapeutics-inc-6095480)
- 2025-06-05 21:23 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-entero-therapeutics-inc-6075056)
- 2025-06-04 20:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-entero-therapeutics-inc-6072255)
- 2025-05-30 21:25 UTC [SEC Form PRER14A filed by Entero Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-prer14a-filed-by-entero-therapeutics-inc-6065856)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ENTO
- Earnings history: https://www.quantisnow.com/earnings/ENTO
- Dividend history: https://www.quantisnow.com/dividends/ENTO
- Insider transactions: https://www.quantisnow.com/insiders/ENTO
- Options chain: https://www.quantisnow.com/options/ENTO
- SEC 8-K filings only: https://www.quantisnow.com/company/ENTO/8-k
- RSS and alerts for ENTO: https://www.quantisnow.com/docs/rss-feeds.md